Fasciola hepatica infection at a University Clinic in Turkey.
BACKGROUND
We aimed to analyze the approaches to the diagnosis and treatment of patients with fascioliasis in light of current literature.


METHODS
Thirty-nine patients with fascioliasis admitted to the Surgery Clinic of Dicle Medical Faculty (Turkey) were included in this study. The demographic, clinical, diagnostic, treatment and outcome data were analyzed retrospectively.


RESULTS
Abdominal pain (n = 37; 95%) and eosinophilia (n = 31; 79%) were the most common findings. Twenty-seven patients were diagnosed by clinical and radiological findings. Patients were treated with triclabendazole. Thirty-six (92.4%) of the patients improved after medical treatment.


CONCLUSIONS
The presence of typical clinical, laboratory and radiological findings is sufficient for diagnosis. Triclabendazole administration is often an effective treatment, with improvements occurring over the course of a few months.
Dicle University Medical Faculty, Diyarbakır, Turkey. bvulger@gmail.com.
Burak Veli
BV
Ulger
Murat
M
Kapan
Abdullah
A
Boyuk
Omer
O
Uslukaya
Abdullah
A
Oguz
Zubeyir
Z
Bozdag
Sadullah
S
Girgin
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D003955:Diagnostic Tests, Routine; D005210:Fasciola hepatica / Q000302:isolation & purification; D005211:Fascioliasis / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006785:Hospitals, University; D006801:Humans; D008297:Male; D008875:Middle Aged; D011859:Radiography; D016896:Treatment Outcome; D000077682:Triclabendazole; D014421:Turkey; D055815:Young Adult
D000871:Anthelmintics; D001562:Benzimidazoles; D000077682:Triclabendazole